MDxHealth S.A.
MXDHF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $90,049 | $70,193 | $37,054 | $22,239 |
| % Growth | 28.3% | 89.4% | 66.6% | – |
| Cost of Goods Sold | $34,908 | $26,264 | $17,835 | $11,675 |
| Gross Profit | $55,141 | $43,929 | $19,219 | $10,564 |
| % Margin | 61.2% | 62.6% | 51.9% | 47.5% |
| R&D Expenses | $10,552 | $6,376 | $7,557 | $5,589 |
| G&A Expenses | $54,954 | $23,010 | $23,539 | $27,194 |
| SG&A Expenses | $61,396 | $59,925 | $50,121 | $30,217 |
| Sales & Mktg Exp. | $6,442 | $36,915 | $26,582 | $3,023 |
| Other Operating Expenses | $7,915 | $4,955 | -$559 | $1,599 |
| Operating Expenses | $79,863 | $71,256 | $57,119 | $37,405 |
| Operating Income | -$24,722 | -$27,327 | -$37,900 | -$26,841 |
| % Margin | -27.5% | -38.9% | -102.3% | -120.7% |
| Other Income/Exp. Net | -$12,965 | -$15,772 | -$6,144 | -$2,161 |
| Pre-Tax Income | -$37,687 | -$43,099 | -$44,044 | -$29,002 |
| Tax Expense | $382 | $1 | $0 | $0 |
| Net Income | -$38,069 | -$43,100 | -$44,044 | -$29,002 |
| % Margin | -42.3% | -61.4% | -118.9% | -130.4% |
| EPS | -0.78 | -1.66 | -2.78 | -2.38 |
| % Growth | 53% | 40.3% | -16.8% | – |
| EPS Diluted | -1.16 | -1.66 | -2.78 | -2.38 |
| Weighted Avg Shares Out | 48,666 | 25,911 | 15,866 | 12,194 |
| Weighted Avg Shares Out Dil | 48,666 | 25,911 | 15,866 | 12,194 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1,078 | $1,088 | $125 | $11 |
| Interest Expense | $7,629 | $5,772 | $2,743 | $1,875 |
| Depreciation & Amortization | $8,039 | $6,859 | $4,909 | $3,036 |
| EBITDA | -$22,019 | -$30,468 | -$36,392 | -$24,091 |
| % Margin | -24.5% | -43.4% | -98.2% | -108.3% |